Risk Factors for Subtherapeutic Tacrolimus Levels after Conversion from Continuous Intravenous Infusion to Oral in Children after Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Risk Factors for Subtherapeutic Tacrolimus Levels after Conversion from Continuous Intravenous Infusion to Oral in Children after Allogeneic Hematopoietic Cell Transplantation

Published:2016-05 Issue:5 Volume:22 Page:957-961
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Kolb Michelle,Offer Katharine,Jin Zhezhen,Kahn Justine,Bhatia Monica,Kung Andrew L.,Garvin James H.,George Diane,Satwani Prakash^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference21 articles.

1. Acute graft-versus-host disease in children;Jacobsohn;Bone Marrow Transplant,2008

2. Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians;Macphee;Transplantation,2005

3. Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement;MacPhee;Transplantation,2002

4. The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation;MacPhee;Am J Transplant,2004

5. Tacrolimus clearance is age-dependent within the pediatric population;Przepiorka;Bone Marrow Transplant,2000

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of tacrolimus vs. cyclosporine in pediatric hematopoietic stem cell transplantation for thalassemia;Pediatric Transplantation;2024-01-26

2. Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral Therapy;Transplantation and Cellular Therapy;2022-01

3. Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipients;Journal of Managed Care & Specialty Pharmacy;2021-07

4. Analyzing the clinical outcomes of switching from cyclosporine to tacrolimus in pediatric hematopoietic stem cell transplantation;Clinical Transplantation;2021-05-03

5. Anaphylaxis Induced by Intravenous Tacrolimus Administration During Kidney Transplant Surgery: A Case Report;Transplantation Proceedings;2021-05